Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.3096 (-99.87%)
At close: Oct 16, 2026
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $16.31 thousand as of October 16, 2026. It is the 51,674th most valuable company in the world and the 7,682nd biggest in the United States. Its market cap has decreased by 99.99% in one year.
Market Cap
16.31K
Enterprise Value
-9.03M
Revenue
n/a
Global Rank
Country Rank
#7,682 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 16.31K, a decrease of -99.99%. That is a compound annual growth rate of -81.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 16.31K | -99.96% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 26.29K |
| Biostax | 21.65K |
| Carisma Therapeutics | 20.92K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Bio-Path Holdings | 16.17K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |